Chronic Bronchitis: Clinical Trials

8 trials for Chronic Bronchitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Completed 8

Follow Chronic Bronchitis: new trials by email Literature Review of Chronic Bronchitis trials Research Report on Chronic Bronchitis

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Explore if Long-term Use of Mucinex Can Help With Symptoms in Patients With Stable Chronic Bronchitis.
Guafenesin tablets - Chronic Bronchitis
Phase 4CompletedAmerican Health Research822023-07-172026-03-20
The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchitis
Roflumilast, Placebo - COPD, Chronic Bronchitis
Phase 4CompletedJohns Hopkins University122013-03-182017-07-27
Efficacy of Losartan in Preventing Progression of COPD
Losartan, Placebo - COPD, Emphysema
Phase 4CompletedJohns Hopkins University1062008-07-012017-04-25
Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic Bronchitis
Avelox (Moxifloxacin, BAY12-8039), Amoxicillin clavulanic acid - Chronic Bronchitis
Phase 4CompletedBayer13722008-03-012014-12-01
Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients
Formoterol plus Placebo (Tiotropium), Formoterol plus Tiotropium - Pulmonary Disease, Chronic Obstructive, Chronic Bronchitis
Phase 4CompletedFederal University of São Paulo332007-11-012010-01-20
Airway Clearance for Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
pneumatic vest, placebo pneumatic vest - COPD, Chronic Bronchitis
Phase 4CompletedJohns Hopkins University502004-05-012018-10-19
PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis
telithromycin - Chronic Bronchitis
Phase 4CompletedSanofi56602004-01-012011-06-08
Inhaled Steroid Reduces Systemic Inflammation in COPD
inhaled fluticasone 500 mcg b.i.d. - Chronic Obstructive Pulmonary Disease, Emphysema
Phase 4CompletedUniversity of British Columbia502002-01-012010-07-28

Narrower conditions

Bronchitis, Chronic (8)  ·  Pulmonary Disease, Chronic Obstructive (6)  ·  Emphysema (4)  ·  Smoking (3)  ·  Lung Diseases (2)  ·  Bronchitis (1)  ·  Dyspnea (1)  ·  Inflammation (1)  ·  Pulmonary Emphysema (1)

Broader conditions

Bronchial Diseases (8)  ·  Chronic Disease (8)  ·  Disease Attributes (8)  ·  Infections (8)  ·  Lung Diseases, Obstructive (8)  ·  Pathologic Processes (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Respiratory Tract Diseases (8)  ·  Respiratory Tract Infections (8)  ·  Bronchitis (7)  ·  Lung Diseases (6)  ·  Behavior (3)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  Respiration Disorders (1)  ·  Signs and Symptoms (1)

Interventions

Sugars (2)  ·  Acetylcysteine (1)  ·  Amoxicillin-Potassium Clavulanate Combination (1)  ·  Formoterol Fumarate (1)  ·  Losartan (1)  ·  Moxifloxacin (1)  ·  Roflumilast (1)  ·  Tiotropium Bromide (1)  ·  telithromycin (1)

Sponsors

Johns Hopkins University (3)  ·  American Health Research (1)  ·  Bayer (1)  ·  Federal University of São Paulo (1)  ·  Sanofi (1)  ·  University of British Columbia (1)

Countries

United States (4)  ·  Belgium (2)  ·  Brazil (2)  ·  Canada (2)  ·  France (2)  ·  Spain (2)  ·  Andorra (1)  ·  Argentina (1)  ·  Australia (1)  ·  Chile (1)  ·  China (1)  ·  Colombia (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Germany (1)

Top investigators

Beth Laube, PhD (1)  ·  Gilles Perdriset, MD (1)  ·  Gregory B Diette, M.D.,M.H.S (1)  ·  J Alberto Neder, MD, phD (1)  ·  Nadia Hansel, MD MPH (1)  ·  Paul Man, MD (1)  ·  Robert A. Wise, MD (1)  ·  Selwyn Spangenthal, MD (1)

Results publications

PMID 15229100, PMID 16113473, PMID 20580216, PMID 21760724, PMID 26082623

NIH funding

P50HL084945 (1)